GO:0045121 membrane raft: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• Membrane rafts (GO:0045121) are small (10-200 nm), heterogeneous, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes.
• Rafts are highly dynamic and can be stabilized into larger platforms through protein-protein and protein-lipid interactions.
• Cholesterol is a key structural component; its depletion disrupts raft integrity and alters signaling and drug responses [1,3,8].
• Rafts are implicated in cancer, neurodegeneration, and multidrug resistance, making them attractive therapeutic targets [1,6,8].
• Key proteins include P-glycoprotein (ABCB1), MPP1, and COX-2, which partition into rafts and modulate drug action [4,5,8].
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable causal dissection of raft-associated gene function [1,5,8].
Description
Membrane rafts (GO:0045121) are small, dynamic, sterol- and sphingolipid-enriched domains in cellular membranes that compartmentalize signaling and trafficking events. They are defined as heterogeneous structures of 10-200 nm that can coalesce into larger platforms via protein-protein and protein-lipid interactions. These domains are critical for organizing receptors, transporters, and signaling molecules, thereby influencing processes ranging from immune response to neuronal function [2,6]. Dysregulation of raft composition or dynamics is linked to cancer progression, neurodegeneration, and drug resistance [1,6,8]. For researchers, understanding rafts requires integrating membrane biology, lipid biochemistry, and advanced imaging and genetic tools [3,7]. This article provides a comprehensive overview of membrane raft components, assembly, regulation, disease relevance, and CRISPR-based research methods.
membrane raft At A Glance
| GO ID | GO:0045121 |
|---|---|
| GO term | membrane raft |
| Ontology | cellular_component |
| Synonym | GEM domain; glycolipid-enriched membrane domain; lipid raft |
| Major function | Compartmentalization of cellular processes; signaling platform assembly |
| Size | 10-200 nm |
| Composition | Sterol- and sphingolipid-enriched; dynamic; heterogeneous |
| Stabilization | Protein-protein and protein-lipid interactions |
What Is GO:0045121?
Membrane rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
Why Is membrane raft Important in Cell Biology?
Membrane rafts are essential for organizing signal transduction, membrane trafficking, and host-pathogen interactions, and their dysfunction contributes to major diseases including cancer, Alzheimer's disease, and multidrug resistance [1,6,8]. Because rafts concentrate receptors and signaling molecules, they serve as hubs for cellular decision-making and are promising targets for therapeutic intervention [3,4].
• Rafts compartmentalize signaling pathways, influencing cell proliferation, survival, and migration.
• Cholesterol depletion disrupts raft integrity and can reverse drug resistance in cancer cells.
• Rafts are involved in the pathogenesis of Alzheimer's disease through amyloid precursor protein processing.
• Membrane rafts modulate the activity of non-steroidal anti-inflammatory drugs by interacting with COX-2.
• Raft-associated proteins such as P-glycoprotein contribute to multidrug resistance in cancer.
• Rafts serve as entry platforms for certain viruses and toxins.
• MPP1 organizes resting-state rafts in erythroid cells, highlighting cell-type-specific mechanisms.
• Rafts are implicated in prostate cancer progression and androgen receptor signaling.
• Targeting rafts with drugs or lipid-modifying agents is a potential therapeutic strategy.
• Advanced models like coarse-grained simulations help study raft-like lipid mixtures.
What Happens During membrane raft?
Raft Formation and Lipid Ordering
In simple terms: Rafts form when certain lipids pack tightly together in the membrane.
Membrane rafts assemble spontaneously due to the preferential packing of sphingolipids and cholesterol, creating a liquid-ordered phase distinct from the surrounding liquid-disordered membrane. This ordering is driven by lipid-lipid interactions and is highly dynamic, with rafts constantly forming and dispersing. Cholesterol is critical for maintaining raft integrity; its depletion leads to raft disruption and altered membrane organization [1,8].
Protein Partitioning and Platform Stabilization
In simple terms: Proteins that prefer ordered lipids gather in rafts, and interactions can stabilize them into larger platforms.
Proteins with saturated lipid modifications (e.g., GPI anchors, palmitoylation) or specific transmembrane domains partition into rafts. Protein-protein and protein-lipid interactions can stabilize small rafts into larger signaling platforms, facilitating efficient signal transduction. For example, MPP1 stabilizes resting-state rafts in erythroid cells through a specialized mechanism.
Signaling and Trafficking
In simple terms: Rafts act as signaling hubs and sorting stations for membrane traffic.
Rafts concentrate receptors, kinases, and adaptor proteins, enabling rapid and specific signaling responses. They also serve as platforms for membrane trafficking, including endocytosis and exocytosis. In cancer, raft-associated P-glycoprotein is trafficked to the cell surface in a raft-dependent manner, contributing to multidrug resistance.
Raft Dynamics and Remodeling
In simple terms: Rafts are not static; they change in response to cellular cues and lipid environment.
Raft size, composition, and stability are dynamically regulated by cellular signals, lipid metabolism, and interactions with the cytoskeleton. Cholesterol trafficking and modifications can alter raft conformers, as seen with P-glycoprotein in multidrug-resistant cells. Coarse-grained simulations reveal that raft-like lipid mixtures exhibit complex phase behavior.
Key Genes Involved in GO:0045121 membrane raft
The following genes and proteins are key components or regulators of membrane rafts, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ABCB1 (P-glycoprotein) | Raft-associated transporter; drug efflux | Multidrug resistance; cholesterol trafficking |
| MPP1 | Resting-state raft organization in erythroid cells | Cell-type-specific raft mechanisms |
| PTGS2 (COX-2) | Raft-interacting enzyme; prostaglandin synthesis | NSAID selectivity and drug interactions |
| APP | Amyloid precursor protein; raft-associated processing | Alzheimer's disease pathogenesis |
| Caveolin-1 | Raft marker protein; caveolae formation | Signaling and cancer |
| FYN | Src-family kinase; raft-associated signaling | Immune and neuronal signaling |
| LYN | Src-family kinase; raft-associated signaling | B-cell signaling |
| GPI-anchored proteins | Raft partitioning via GPI anchors | General raft biology |
| Sphingomyelin synthase | Sphingolipid synthesis; raft composition | Lipid metabolism |
| HMGCR | Cholesterol synthesis; raft cholesterol supply | Cholesterol regulation |
| NPC1 | Cholesterol trafficking; raft integrity | Niemann-Pick disease |
| ABCA1 | Cholesterol efflux; raft modulation | Cardiovascular disease |
| TLR4 | Raft-associated receptor; innate immunity | Inflammation |
| TCR | T-cell receptor; raft signaling | Immune response |
| EGFR | Raft-associated receptor tyrosine kinase | Cancer signaling |
| Integrins | Raft-associated adhesion receptors | Cell migration |
| Rho GTPases | Cytoskeleton-raft crosstalk | Membrane dynamics |
How Is membrane raft Regulated?
Membrane raft organization is regulated by cholesterol levels, sphingolipid metabolism, and protein-protein interactions [1,2]. Cholesterol depletion disrupts rafts, while increased cholesterol trafficking can stabilize raft conformers, as observed in multidrug-resistant cells. MPP1-based mechanisms regulate resting-state raft organization in erythroid cells. Additionally, drug interactions with raft domains can modulate signaling, as shown for NSAIDs and COX-2.
membrane raft and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCB1 | Multidrug resistance in cancer | KO and overexpression in MDR cell lines |
| APP | Alzheimer's disease | Knock-in of familial AD mutations in neurons |
| PTGS2 | Inflammation and NSAID response | Point mutation of COX-2 active site |
| MPP1 | Erythroid raft organization | KO in erythroid progenitor cells |
| HMGCR | Cholesterol metabolism and cancer | Overexpression and KO in prostate cancer cells |
Membrane Rafts in Cancer
Membrane rafts are implicated in cancer progression, where they concentrate growth factor receptors and signaling molecules that promote proliferation and survival. In prostate cancer, cholesterol-driven raft domains contribute to tumorigenesis and androgen receptor signaling. Raft-associated P-glycoprotein mediates multidrug resistance by effluxing chemotherapeutic drugs, and cholesterol depletion can reverse this resistance. Targeting raft composition or dynamics is a potential therapeutic strategy.
Membrane Rafts in Neurodegeneration
In Alzheimer's disease, neuronal membranes and rafts play key roles in amyloid precursor protein processing and amyloid-beta production. Both raft and non-raft domains contribute to pathogenesis, with raft-associated enzymes like beta-secretase and gamma-secretase complex components. Disruption of raft integrity may alter amyloidogenic processing and neuronal function.
Membrane Rafts in Drug Resistance and Inflammation
Rafts modulate drug action and resistance. NSAIDs interact with lipid raft domains, affecting COX-2 selectivity and anti-inflammatory activity. In multidrug-resistant cancer cells, enhanced cholesterol trafficking carries a raft conformer of P-glycoprotein to the cell surface, conferring resistance to cholesterol modifications. These findings highlight rafts as modulators of drug efficacy [3,4].
From membrane raft-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ABCB1 affect raft-mediated drug efflux? | CRISPR KO of ABCB1 in MDR cancer cells |
| How does a point mutation in PTGS2 alter raft interaction? | CRISPR point mutation knock-in of COX-2 variants |
| Can a tagged raft protein be tracked in live cells? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of MPP1 stabilize rafts? | CRISPR overexpression via safe-harbor integration |
| What is the role of cholesterol synthesis in raft dynamics? | KO of HMGCR or ABCA1 in cancer cells |
| How do disease mutations in APP affect raft processing? | Knock-in of APP mutations in iPSC-derived neurons |
How to Study the membrane raft Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Detergent-resistant membrane isolation | Raft-associated proteins and lipids | Biochemical characterization |
| Super-resolution microscopy | Raft size, dynamics, and clustering | Live-cell imaging |
| Proteomics | Protein composition of rafts | Identification of raft proteins |
| Lipidomics | Sterol and sphingolipid content | Raft lipid composition |
| Cholesterol depletion assays | Raft dependence of processes | Functional validation [1,8] |
| Drug efflux assays | P-glycoprotein activity | Multidrug resistance studies |
| Coarse-grained simulations | Raft-like lipid mixture behavior | Theoretical modeling |
| CRISPR KO/knock-in | Gene function in raft biology | Causal studies [5,8] |
Membrane Fractionation and Detergent Resistance
Membrane rafts are traditionally isolated as detergent-resistant membranes (DRMs) using cold non-ionic detergents and density gradient centrifugation. This method enriches for sterol- and sphingolipid-rich domains but must be interpreted cautiously due to potential artifacts. Combining with cholesterol depletion controls validates raft specificity.
Advanced Imaging of Rafts
Super-resolution microscopy, single-molecule tracking, and fluorescence correlation spectroscopy enable visualization of rafts in live cells. These techniques reveal dynamic clustering and size of rafts, which are below the diffraction limit. Coarse-grained simulations complement imaging by modeling raft-like lipid mixtures.
Proteomics and Lipidomics
Mass spectrometry-based proteomics identifies raft-associated proteins, while lipidomics quantifies sterol and sphingolipid composition. These approaches reveal dynamic changes in raft composition under different conditions, such as drug treatment or cholesterol modulation [3,4].
Functional Assays for Raft-Dependent Processes
Signaling assays, drug efflux measurements, and membrane trafficking studies assess raft function. Cholesterol depletion using methyl-beta-cyclodextrin is a common tool to disrupt rafts and test dependence [1,8]. CRISPR-based genetic models provide causal validation [5,8].
How CRISPR Can Be Used to Study GO:0045121 membrane raft
Knockout
CRISPR knockout of raft-associated genes such as ABCB1 or MPP1 enables loss-of-function studies to determine their role in raft organization and function [5,8]. For example, ABCB1 knockout reverses multidrug resistance and alters raft-mediated drug efflux.
Point Mutation
Point mutations can be introduced into genes like PTGS2 to dissect specific residues involved in raft interaction or drug binding. This approach reveals how single amino acid changes affect raft partitioning and function.
Knock-in
Knock-in of tags (e.g., GFP) or disease-associated mutations (e.g., APP) allows tracking of raft proteins in live cells and modeling of disease mechanisms [2,6]. Tagged knock-ins preserve endogenous regulation and localization.
Overexpression
CRISPR-mediated overexpression of raft proteins like MPP1 or cholesterol regulators can test gain-of-function effects on raft stability and signaling [1,5]. Overexpression models are useful for studying raft-driven oncogenic signaling.
How EDITGENE Supports membrane raft Research
Researchers studying membrane raft-related genes often need to determine whether a candidate gene is causally involved in raft organization, signaling, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of raft-associated genes.
Contact EDITGENE today to design your custom CRISPR model for membrane raft research.
Frequently Asked Questions About membrane raft
What is a membrane raft (GO:0045121)?
Membrane rafts are small (10-200 nm), heterogeneous, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes and can stabilize into larger platforms.
What genes are involved in membrane rafts?
Key genes include ABCB1, MPP1, PTGS2, APP, CAV1, and FYN, among others, which partition into rafts or regulate their dynamics [2,4,5,6,8].
How are membrane rafts studied?
Common methods include detergent-resistant membrane isolation, super-resolution imaging, proteomics, lipidomics, and CRISPR-based genetic models [2,7,8].
What is the role of cholesterol in membrane rafts?
Cholesterol is a critical structural component; its depletion disrupts raft integrity and alters signaling and drug responses [1,8].
Are membrane rafts involved in cancer?
Yes, rafts concentrate signaling receptors and contribute to cancer progression and multidrug resistance, making them therapeutic targets [1,8].
How do membrane rafts relate to Alzheimer's disease?
Rafts participate in amyloid precursor protein processing and amyloid-beta production, contributing to Alzheimer's pathogenesis.
What is the difference between lipid rafts and membrane rafts?
They are synonymous terms; membrane raft is the official GO term (GO:0045121) for these sterol- and sphingolipid-enriched domains.
Can CRISPR be used to study membrane rafts?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of raft-associated genes [5,8].
What proteins are enriched in membrane rafts?
GPI-anchored proteins, palmitoylated proteins, caveolin-1, Src-family kinases, and P-glycoprotein are commonly enriched [2,8].
How does P-glycoprotein relate to membrane rafts?
P-glycoprotein partitions into rafts, and its raft conformer is trafficked to the cell surface in multidrug-resistant cells, contributing to drug resistance.
Conclusion
Membrane rafts (GO:0045121) are dynamic, sterol- and sphingolipid-enriched domains that organize signaling and trafficking, with critical roles in cancer, neurodegeneration, and drug resistance [1,2,6,8]. Understanding their composition, assembly, and regulation requires integrated biochemical, imaging, and genetic approaches [2,7]. CRISPR-based models provide powerful tools to dissect the causal roles of raft-associated genes, and EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Hryniewicz-Jankowska A et al.. 2019. The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer.. Exp Biol Med (Maywood) 244(13):1053-1061 PMID: 31573840
- 2. Sonnino S et al.. 2013. Membrane domains and the "lipid raft" concept.. Curr Med Chem 20(1):4-21 PMID: 23150999
- 3. Tsuchiya H et al.. 2020. Interaction of drugs with lipid raft membrane domains as a possible target.. Drug Target Insights 14:34-47 PMID: 33510571
- 4. Mizogami M et al.. 2025. Lipid Raft Membrane Interactivity Correlating with Cyclooxygenase-2 Selectivity of Non-Steroidal Anti-Inflammatory Drugs.. Membranes (Basel) 15(9) PMID: 41002919
- 5. Trybus M et al.. 2019. MPP1-based mechanism of resting state raft organization in the plasma membrane. Is it a general or specialized mechanism in erythroid cells?. Folia Histochem Cytobiol 57(2):43-55 PMID: 31099889
- 6. Williamson R et al.. 2011. Neuronal membranes are key to the pathogenesis of Alzheimer's disease: the role of both raft and non-raft membrane domains.. Curr Alzheimer Res 8(2):213-21 PMID: 21222605
- 7. Varma M et al.. 2024. Raft-like lipid mixtures in the highly coarse-grained Cooke membrane model.. J Chem Phys 161(11) PMID: 39282832
- 8. Gutay-Tóth Z et al.. 2023. Cholesterol-Depletion-Induced Membrane Repair Carries a Raft Conformer of P-Glycoprotein to the Cell Surface, Indicating Enhanced Cholesterol Trafficking in MDR Cells, Which Makes Them Resistant to Cholesterol Modifications.. Int J Mol Sci 24(15) PMID: 37569709
